Back
Biogen Quote, Financials, Valuation and Earnings
Sponsored
BIIB
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
37
BIIB
Biogen
Last Price:
199.29
Seasonality Move:
9.16%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Biogen Price Quote
$199.29
-0.07 (-1.07%)
(Updated: September 21, 2024 at 6:13 AM ET)
Biogen Key Stats
Sell
37
Biogen (BIIB)
is a Sell
Day range:
$196.97 - $200.37
52-week range:
$189.44 - $269.43
Dividend yield:
0%
P/E ratio:
25.01
P/S ratio:
3.00
P/B ratio:
1.83%
Volume:
3.8M
Avg. volume:
884.3K
1-year change:
-23.48%
Market cap:
$29B
Revenue:
$9.8B
EPS:
$7.94
How Much Does Biogen Make?
Is Biogen Growing As A Company?
Biogen Stock Price Performance
What Is Biogen 52-Week High & Low?
Biogen Price To Free Cash Flow
-
Is Biogen Stock Overvalued?
Biogen is trading at a price to free cash flow ratio of 19.78 -
Is Biogen Stock Undervalued?
Biogen EV to Free Cash Flow ratio is 22.77 -
What Is Biogen’s Price Earnings Growth Ratio?
BIIB PEG ratio is 0.00 -
Is Biogen Trading At A Premium To Earnings?
Biogen EV to EBIT ratio is 21.16
Is It Risky To Buy Biogen?
Is Biogen Cash Flow Positive?
Biogen Return On Invested Capital
Biogen Earnings Date & Stock Price
-
What Is Biogen's Stock Price Today?
A single share of BIIB can be purchased today for 199.36 -
What Is Biogen’s Stock Symbol?
Biogen trades on the S&P500 under the ticker symbol: BIIB -
When Is Biogen’s Next Earnings Date?
The next quarterly earnings date for Biogen is scheduled on November 8, 2024 -
When Is BIIB's next ex-dividend date?
Biogen's next ex-dividend date is June 18, 2020 -
How To Buy Biogen Stock?
You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biogen Competitors
Biogen Dividend Yield
Biogen Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -1.72% | 31.03% |
Revenue: | 0.36% | 3.3% |
Analyst Recommendations
Buy Recommendations: | 16 |
---|---|
Hold Recommendations: | 9 |
Sell Recommendations: | 0 |
Price Target: | 271.42 |
Upside from Last Price: | 36.15% |